Emotional disturbances, social outcome and neurocognitive function in advanced melanoma survivors treated with pembrolizumab

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
Article number07
JournalJournal of Translational Medicine
Volume17
Issue numberS1
Publication statusPublished - 15 Jan 2019
EventImmunotherapy Bridge 2018 and Melanoma Bridge 2018 - Napoli, Italy
Duration: 28 Nov 20181 Dec 2018

Keywords

  • advanced melanoma survivors
  • pembrolizumab

Cite this